Validating Neuropsych Tests in Spanish-speakers

Rehabilitation Hospital of Indiana

Status: Unknown

Conditions: Testing; Neuropsychology

Treatments: Diagnostic Test: Neuropsychological testing

Study type: Interventional

Funder types: Other

Identifiers

NCT05185635

11390

Details and patient eligibility

About

The proposed pilot further emphasizes the need for collecting language and demographic specific norms for Spanish-speaking Latino individuals in the U.S. by developing new normative test data for this demographic population. The study looks to contribute to minimize healthcare disparities and inaccurate test interpretations, which can have direct implications on diagnosis and treatment. This study will allow us to develop new neuropsychological test norms for predominantly Spanish-speaking adults by establishing expected cognitive performance on a battery of frequently used neuropsychological tests. As such, the current study will help fill a large gap in the literature pertaining to neuropsychological assessment of Spanish-Speakers living in the U.S., as well as produce data of clinical utility for providers working with this population. Finally, this pilot could serve as a model to eventually extend it to other non-English speaking populations in the US.

Full description

Hispanics/Latinos are now recognized as the largest and fastest growing ethnic/racial minority group in the United States (U.S.). By 2017, the Hispanic/Latino population reached nearly 60 million comprising 18% of the total U.S. population. Current projections indicate that Hispanic/Latinos will reach almost 111 million, making up 28% of the total U.S. population by 2060.

Clinical neuropsychologists must be equipped with the right tools to accurately serve the rapidly growing Hispanic/Latino population in the US. Findings from normative data studies in foreign countries emphasize the need for developing language and demographic specific norms for Spanish-speaking Hispanics in the US. This is particularly relevant given recent literature indicating that factors such as ethnicity, language, quality of education, degree of acculturation, and bilingualism can have a profound impact on neuropsychological test performance. Within participants that self-identify as primarily Spanish-speaking, language performance has been positively associated with greater Spanish vs. English language dominance and completing education outside the U.S., whereas other cognitive abilities have a negative association with the same variables.

The proposed pilot further emphasizes the need for collecting language and demographic specific norms for Spanish-speaking Latino individuals in the U.S. by developing new normative test data for this demographic population. The study looks to contribute to minimize healthcare disparities and inaccurate test interpretations, which can have direct implications on diagnosis and treatment. This study will allow us to develop new neuropsychological test norms for predominantly Spanish-speaking adults by establishing expected cognitive performance on a battery of frequently used neuropsychological tests. As such, the current study will help fill a large gap in the literature pertaining to neuropsychological assessment of Spanish-Speakers living in the U.S., as well as produce data of clinical utility for providers working with this population. Finally, this pilot could serve as a model to eventually extend it to other non-English speaking populations in the US.

Enrollment: 40 estimated patients

Sex: All

Ages: 18 to 80 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Be between 18 to 80 years of age
• Have been living in the US for at least 1 year (12 continuous months)
• Identify Spanish as their primary and/or dominant language
• Have at least one year of formal education
• Be able to read and write at the time of evaluation in Spanish
• a score of ≥23 on the Mini-Mental State Examination (MMSE)
• score of ≤10 on the Patient Health Questionnaire-9 (PHQ-9)
• score of ≤10 on the generalized anxiety disorder (GAD-7)

Exclusion criteria

• History of neurodevelopmental disorder
• History of learning disorder
• Past or present neurologic condition
• Past or present chronic medical condition that may affect cognition (i.e. metabolic syndrome, chronic heart failure, sleep apnea)
• Past or present use of psychotropic medications that may affect cognition
• Past or present history of substance abuse or dependence
• Past or present history of psychiatric disorder
• Presence of severe sensory deficits, such as loss of hearing or vision

Trial design

Primary purpose: Health Services Research

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

40 participants in 1 patient group

Healthy Spanish-speakers

Experimental group

Treatment:

Diagnostic Test: Neuropsychological testing